GlassScriptPhysician profile
Michelle M Kim
NPI 1609213867
$8,823.34
in general payments reported to CMS, 2019-2025
13 companies · $5,208 in 2025
The $5,208 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,780 · 2021: $934 · 2022: $445 · 2023: $119 · 2024: $338 · 2025: $5,208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,695 · Travel and Lodging: $1,002 · Food and Beverage: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,695.00 |
| Travel and Lodging | $1,001.77 |
| Food and Beverage | $967.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gyrus Acmi, INC. | $4,325.00 | 2025 | Soltive, Medical Control Unit For Endosurgery Uces-4 |
| Civco Medical Instruments | $1,334.00 | 2021-2022 | |
| Boston Scientific Corporation | $1,199.54 | 2019 | |
| Procept Biorobotics Corporation | $554.18 | 2019 | |
| Medtronic, INC. | $380.75 | 2022-2025 | Accuvac |
| Intuitive Surgical, INC. | $371.77 | 2025 | |
| Paragonix Technologies, INC. | $190.03 | 2024 | |
| Janssen Biotech, INC. | $153.46 | 2025 | Erleada |
| Abbvie INC. | $147.78 | 2023-2024 | |
| Zimvie INC. | $97.54 | 2024 | |
| Portola Pharmaceuticals, LLC | $26.38 | 2019 | |
| Photocure INC | $21.68 | 2024 | Cysview |
| Allergan, INC. | $21.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.